Modulation Therapeutics
Dr. William (Bill) S. Dalton is President, CEO & Center Director of Moffitt Cancer Center, an NCI-Designated Comprehensive Cancer Center, and serves as Founder & Board Chairman of M2Gen, a national biotechnology subsidiary of Moffitt Cancer Center.
This person is not in the org chart
This person is not in any teams
This person is not in any offices
Modulation Therapeutics
Modulation Therapeutics is a pharmaceutical company developing novel compounds for the treatment of multiple myeloma.